Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival

被引:31
作者
Galleu, Antonio [1 ,2 ]
Milojkovic, Dragana [3 ]
Deplano, Simona [3 ]
Szydlo, Richard [4 ]
Loaiza, Sandra [3 ]
Wynn, Robert [5 ]
Marks, David I. [6 ]
Richardson, Deborah [7 ]
Orchard, Kim [7 ]
Kanfer, Edward [3 ]
Tholouli, Eleni [5 ]
Saif, Muhammad [5 ]
Sivaprakasam, Ponni [6 ]
Lawson, Sarah [8 ]
Bloor, Adrian [9 ]
Pagliuca, Antonio [10 ]
Potter, Victoria [10 ]
Mehra, Varun [10 ]
Snowden, John A. [11 ]
Vora, Ajay [12 ]
Kishore, Bhuvan [13 ]
Hunter, Hannah [14 ]
Apperley, Jane F. [3 ,4 ]
Dazzi, Francesco [1 ,2 ,3 ,4 ]
机构
[1] Kings Coll London, London, England
[2] Kings Hlth Partners Canc Res UK Ctr, London, England
[3] Imperial Coll Healthcare NHS Trust, London, England
[4] Imperial Coll London, London, England
[5] Cent Manchester Univ Hosp, Manchester, Lancs, England
[6] Univ Hosp Bristol, Bristol, Avon, England
[7] Southampton Univ Hosp, Southampton, Hants, England
[8] Birmingham Womens & Childrens Hosp, Birmingham, W Midlands, England
[9] Christie NHS Fdn Trust, Manchester, Lancs, England
[10] Kings Coll Hosp NHS Trust, London, England
[11] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England
[12] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England
[13] NHS Fdn Trust, Heart England, Birmingham, W Midlands, England
[14] Plymouth Hosp NHS Trust, Plymouth, Devon, England
关键词
cellular therapies; GvHD; mesenchymal cells; clinical research; stromal cells; STEM-CELLS; STEROID-RESISTANT; ACUTE GVHD; GRADE III; THERAPY;
D O I
10.1111/bjh.15749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mesenchymal stromal cells (MSCs) have been successfully used for the treatment of steroid-resistant graft-versus-host-disease (GvHD). However, the lack of early predictors of clinical responses impacts on the time at which to add further treatment and consequently the design of informative clinical trials. Here, we present the UK experience of one of the largest cohorts of GvHD patients undergoing MSC infusions so far reported. We show that clinical responses assessed as early as 1 week after MSC infusion predict patients' overall survival. In our cohort, cell dose, patients' age and type of organ involvement are crucial factors associated with clinical responses.
引用
收藏
页码:89 / 92
页数:4
相关论文
共 15 条
[1]   Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM) [J].
Bader, Peter ;
Kuci, Zyrafete ;
Bakhtiar, Shahrzad ;
Basu, Oliver ;
Bug, Gesine ;
Dennis, Michael ;
Greil, Johann ;
Barta, Aniko ;
Kallay, Krisztian M. ;
Lang, Peter ;
Lucchini, Giovanna ;
Pol, Raj ;
Schulz, Ansgar ;
Sykora, Karl-Walter ;
von Luettichau, Irene ;
Herter-Sprie, Grit ;
Uddin, Mohammad Ashab ;
Jenkin, Phil ;
Alsultan, Abdulrahman ;
Buechner, Jochen ;
Stein, Jerry ;
Kelemen, Agnes ;
Jarisch, Andrea ;
Soerensen, Jan ;
Salzmann-Manrique, Emilia ;
Hutter, Martin ;
Schaefer, Richard ;
Seifried, Erhard ;
Klingebiel, Thomas ;
Bonig, Halvard ;
Kuci, Selim .
BONE MARROW TRANSPLANTATION, 2018, 53 (07) :852-862
[2]   Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease [J].
Ball, Lynne M. ;
Bernardo, Maria E. ;
Roelofs, Helene ;
van Tol, Maarten J. D. ;
Contoli, Benedetta ;
Zwaginga, Jaap Jan ;
Avanzini, Maria Antonia ;
Conforti, Antonella ;
Bertaina, Alice ;
Giorgiani, Giovanna ;
Jol-van der Zijde, Cornelia M. ;
Zecca, Marco ;
Le Blanc, Katarina ;
Frassoni, Francesco ;
Egeler, Rudolph Maarten ;
Fibbe, Willem E. ;
Lankester, Arjan C. ;
Locatelli, Franco .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (04) :501-509
[3]   Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation [J].
Dotoli, G. M. ;
De Santis, G. C. ;
Orellana, M. D. ;
de Lima Prata, K. ;
Caruso, S. R. ;
Fernandes, T. R. ;
Rensi Colturato, V. A. ;
Kondo, A. T. ;
Hamerschlak, N. ;
Simoes, B. P. ;
Covas, D. T. .
BONE MARROW TRANSPLANTATION, 2017, 52 (06) :859-862
[4]   Graft-versus-host disease [J].
Ferrara, James L. M. ;
Levine, John E. ;
Reddy, Pavan ;
Holler, Ernst .
LANCET, 2009, 373 (9674) :1550-1561
[5]   Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation [J].
Galleu, Antonio ;
Riffo-Vasquez, Yanira ;
Trento, Cristina ;
Lomas, Cara ;
Dolcetti, Luigi ;
Cheung, Tik Shing ;
von Bonin, Malte ;
Barbieri, Laura ;
Halai, Krishma ;
Ward, Sophie ;
Weng, Ling ;
Chakraverty, Ronjon ;
Lombardi, Giovanna ;
Watt, Fiona M. ;
Orchard, Kim ;
Marks, David I. ;
Apperley, Jane ;
Bornhauser, Martin ;
Walczak, Henning ;
Bennett, Clare ;
Dazzi, Francesco .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (416)
[6]   Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease [J].
Kebriaei, Partow ;
Isola, Luis ;
Bahceci, Erkut ;
Holland, Kent ;
Rowley, Scott ;
McGuirk, Joseph ;
Devetten, Marcel ;
Jansen, Jan ;
Herzig, Roger ;
Schuster, Michael ;
Monroy, Rod ;
Uberti, Joseph .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (07) :804-811
[7]   Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients [J].
Kurtzberg, Joanne ;
Prockop, Susan ;
Teira, Pierre ;
Bittencourt, Henrique ;
Lewis, Victor ;
Chan, Ka Wah ;
Horn, Biljana ;
Yu, Lolie ;
Talano, Julie-An ;
Nemecek, Eneida ;
Mills, Charles R. ;
Chaudhury, Sonali .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) :229-235
[8]   Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study [J].
LeBlanc, Katarina ;
Frassoni, Francesco ;
Ball, Lynne ;
Locatelli, Franco ;
Roelofs, Helene ;
Lewis, Ian ;
Lanino, Edoardo ;
Sundberg, Berit ;
Bernardo, Maria Ester ;
Remberger, Mats ;
Dini, Giorgio ;
Egeler, R. Maarten ;
Bacigalupo, Andrea ;
Fibbe, Willem ;
Ringden, Olle .
LANCET, 2008, 371 (9624) :1579-1586
[9]   The immunomodulatory properties of mesenchymal stem cells [J].
Marigo, Ilaria ;
Dazzi, Francesco .
SEMINARS IN IMMUNOPATHOLOGY, 2011, 33 (06) :593-602
[10]   Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study [J].
Muroi, Kazuo ;
Miyamura, Koichi ;
Okada, Masaya ;
Yamashita, Takuya ;
Murata, Makoto ;
Ishikawa, Takayuki ;
Uike, Naokuni ;
Hidaka, Michihiro ;
Kobayashi, Ryoji ;
Imamura, Masahiro ;
Tanaka, Junji ;
Ohashi, Kazuteru ;
Taniguchi, Shuichi ;
Ikeda, Takashi ;
Eto, Tetsuya ;
Mori, Masaki ;
Yamaoka, Mariko ;
Ozawa, Keiya .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) :243-250